Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women
Dr. Kemi Doll discussed the results of her JAMA Oncology study saying, “These findings suggest that the transvaginal ultrasonography triage strategy is not reliable among Black adults at risk for endometrial cancer.” Medscape also covered the study.
What to know about skin cancer risks: HealthLink
Dr. Lindsay Gunnell explained why skin cancer rates are increasing in Washington: “There's a false sense of security here with our cloud cover that we're getting protection.”
Active Surveillance Viable Option for Some With Prostate Cancer
Dr. Lisa Newcomb commented on her recent study of active surveillance for prostate cancer. She said, “These results demonstrate active surveillance as an effective management strategy for patients diagnosed with favorable-risk prostate cancer.”
Addressing fertility concerns for female patients with sarcoma
Dr. Elizabeth Loggers spoke about cancer treatment and fertility: “After you start treatment, you may already have some lasting effects on your fertility. It is important to have that conversation upfront and to act if it is important to you.”
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
FDA approves new blood test to screen for colon cancer
Dr. Bill Grady emphasized: “What breaks my heart is that it’s preventable. One of my biggest joys is when I’m doing colonoscopy and I can take out polyps.” Grady was also quoted in stories in Axios, CNN, MedPage Today and VeryWell Health.
Myeloma-related questions to ask after diagnosis
Dr. Rahul Banerjee recommended that patients ask their oncologists for trusted sources of information. He said, “I think patient support groups for my patients have been tremendously important because they learn from each other.”
There’s more data for trans people with HIV than any other disease — but it’s still flawed
Brian Minalga discussed the lack of health data about trans people: “Even though trans people are participating in clinical research and giving our biospecimens, our blood, our tissues, our time... [those data] don’t make it back to us.”